Exact Mass: 359.137748
Exact Mass Matches: 359.137748
Found 91 metabolites which its exact mass value is equals to given mass value 359.137748,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Rabeprazole
C18H21N3O3S (359.13035560000003)
Rabeprazole is a proton pump inhibitor sold (as its sodium salt) under the brand names Aciphex and Pariet (distributed by Janssen-Cilag); Rabeprazole is a proton pump inhibitor sold (as its sodium salt) and it is used in the treatment of gastric ulcers and GERD (or heartburn). It is taken once a day along with a full glass of water (preferable 30 min before breakfast). [HMDB] Rabeprazole is a proton pump inhibitor sold (as its sodium salt) under the brand names Aciphex and Pariet (distributed by Janssen-Cilag); Rabeprazole is a proton pump inhibitor sold (as its sodium salt) and it is used in the treatment of gastric ulcers and GERD (or heartburn). It is taken once a day along with a full glass of water (preferable 30 min before breakfast). A - Alimentary tract and metabolism > A02 - Drugs for acid related disorders > A02B - Drugs for peptic ulcer and gastro-oesophageal reflux disease (gord) > A02BC - Proton pump inhibitors C78276 - Agent Affecting Digestive System or Metabolism > C29701 - Anti-ulcer Agent > C29723 - Proton Pump Inhibitor D005765 - Gastrointestinal Agents > D000897 - Anti-Ulcer Agents D004791 - Enzyme Inhibitors > D054328 - Proton Pump Inhibitors
Clethodim
C17H26ClNO3S (359.1321836000001)
D010575 - Pesticides > D006540 - Herbicides D016573 - Agrochemicals
N-[2-hydroxy-2-(4-hydroxy-3-methoxyphenyl)ethyl]-3-(4-hydroxy-3-methoxyphenyl)prop-2-enimidic acid
C19H21NO6 (359.13688060000004)
Chlorambucil-tertiary butyl ester
D000970 - Antineoplastic Agents > D018906 - Antineoplastic Agents, Alkylating > D009588 - Nitrogen Mustard Compounds
Clethodim
C17H26ClNO3S (359.1321836000001)
Oxodipine
C19H21NO6 (359.13688060000004)
N-[2-(3,4-dihydroxyphenyl)-2-hydroxyethyl]-3-(3,4-dimethoxyphenyl)prop-2-enamide
C19H21NO6 (359.13688060000004)
3-O-acetylungiminorine|3-O-Acetylungminorine|ungiminorine acetate
C19H21NO6 (359.13688060000004)
4,6,7-Trimethoxy-5-(2-hydroperoxy-3-methyl-3-butenyl)furo[2,3-b]quinoline
C19H21NO6 (359.13688060000004)
(E)-1,1-dimethyl-3-(4,6,7-trimethoxyfuro[2,3-b]quinolin-5-yl)-2-propenyl hydroperoxide
C19H21NO6 (359.13688060000004)
2-methoxycassiarin B-3-one|cassiarin H
C19H21NO6 (359.13688060000004)
(+)-3alpha-methoxy-6beta-acetylbulbispermine
C19H21NO6 (359.13688060000004)
rabeprazole
C18H21N3O3S (359.13035560000003)
A - Alimentary tract and metabolism > A02 - Drugs for acid related disorders > A02B - Drugs for peptic ulcer and gastro-oesophageal reflux disease (gord) > A02BC - Proton pump inhibitors C78276 - Agent Affecting Digestive System or Metabolism > C29701 - Anti-ulcer Agent > C29723 - Proton Pump Inhibitor D005765 - Gastrointestinal Agents > D000897 - Anti-Ulcer Agents D004791 - Enzyme Inhibitors > D054328 - Proton Pump Inhibitors
(S)-1,2,3,4-tetrahydro-1-phenylisoquinoline D-(-)-tartrate
C19H21NO6 (359.13688060000004)
DIETHYL 1-BENZYL-3,4-ETHYLENEDIOXYPYRRO&
C19H21NO6 (359.13688060000004)
TRANS-1-(TERT-BUTOXYCARBONYL)-4-(3-(TRIFLUOROMETHYL)PHENYL)PYRROLIDINE-3-CARBOXYLIC ACID
C17H20F3NO4 (359.1344356000001)
(4-(N-(2-((TERT-BUTYLDIMETHYLSILYL)OXY)ETHYL)SULFAMOYL)PHENYL)BORONIC ACID
(5R)-5-[(1S)-1,2-Dihydroxyethyl]-3,4-dihydroxy-2(5H)-furanone - 1 ,1-diphenylmethanamine (1:1) (non-preferred name)
C19H21NO6 (359.13688060000004)
Oxodipine
C19H21NO6 (359.13688060000004)
C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C333 - Calcium Channel Blocker D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators C93038 - Cation Channel Blocker
Dimefline Hydrochloride
C20H22ClNO3 (359.1288132000001)
C78272 - Agent Affecting Nervous System > C47795 - CNS Stimulant
(3S,4R)-1-(TERT-BUTOXYCARBONYL)-4-(4-(TRIFLUOROMETHYL)PHENYL)PYRROLIDINE-3-CARBOXYLIC ACID
C17H20F3NO4 (359.1344356000001)
Dexrabeprazole
C18H21N3O3S (359.13035560000003)
A - Alimentary tract and metabolism > A02 - Drugs for acid related disorders > A02B - Drugs for peptic ulcer and gastro-oesophageal reflux disease (gord) > A02BC - Proton pump inhibitors D005765 - Gastrointestinal Agents > D000897 - Anti-Ulcer Agents D004791 - Enzyme Inhibitors > D054328 - Proton Pump Inhibitors
Isopropyl 2-[4-(3-chlorophenyl)piperazino]nicotinate
C19H22ClN3O2 (359.14004620000003)
4-(benzenesulfonyl)-N-methyl-N-phenyl-1-piperazinecarboxamide
C18H21N3O3S (359.13035560000003)
2-[[6-(3,4-Dimethoxyphenyl)-3-pyridazinyl]thio]-1-(1-pyrrolidinyl)ethanone
C18H21N3O3S (359.13035560000003)
N-(5-methyl-1,3,4-oxadiazol-2-yl)-3-(2-methylphenyl)-1-phenylpyrazole-4-carboxamide
7-Deoxyloganate
C16H23O9- (359.13420080000003)
A monocarboxylic acid anion that is the conjugate base of 7-deoxyloganic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3.
N-(4-{[2-(pyridin-3-yl)piperidin-1-yl]sulfonyl}phenyl)acetamide
C18H21N3O3S (359.13035560000003)
N-(4-acetamidophenyl)-2-[(5-cyclopropyl-4-ethyl-1,2,4-triazol-3-yl)thio]acetamide
C17H21N5O2S (359.14158860000003)
1-(2-Fluorophenyl)-4-[(6-nitro-1,3-benzodioxol-5-yl)methyl]piperazine
C18H18FN3O4 (359.12812800000006)
1-[4-(3,4-dihydro-2H-1,5-benzodioxepin-7-yl)-2-thiazolyl]-4-piperidinecarboxamide
C18H21N3O3S (359.13035560000003)
N-[2-[(2-methylphenyl)methylthio]ethyl]-3-[(4-methylphenyl)thio]propanamide
1-(4-Chlorophenyl)-3-[[1-(4-methoxyphenyl)-3-pyrrolidinyl]methyl]urea
C19H22ClN3O2 (359.14004620000003)
N-hydroxy-N-[(E)-(4-thiophen-2-ylphenyl)methylideneamino]heptanediamide
C18H21N3O3S (359.13035560000003)
N-[2-(4-Methoxy-phenyl)-6-methyl-2H-benzotriazol-5-yl]-nicotinamide
[3-[(2-Chlorophenoxy)methyl]phenyl]-(2,6-dimethyl-4-morpholinyl)methanone
C20H22ClNO3 (359.1288132000001)
N-[4-[[(1-oxohexylamino)-sulfanylidenemethyl]amino]phenyl]-2-furancarboxamide
C18H21N3O3S (359.13035560000003)
[4-(5-Chloro-2-methylphenyl)-1-piperazinyl]-(2-ethoxy-3-pyridinyl)methanone
C19H22ClN3O2 (359.14004620000003)
N-[2-(tert-butylamino)-2-oxo-1-pyridin-4-ylethyl]-N-cyclopropyl-4-thiadiazolecarboxamide
C17H21N5O2S (359.14158860000003)
N-cyclohexyl-2-[(6-hydroxy-4-oxo-1-phenyl-2-pyrimidinyl)thio]acetamide
C18H21N3O3S (359.13035560000003)
AVN-492
C17H21N5O2S (359.14158860000003)
AVN-492 is a very specific and highly-selective antagonist with picomolar affinity to 5-HT6R (Ki=91 pM).
(1s,16r,17s,18s,19s)-16-hydroxy-17-methoxy-5,7-dioxa-12-azapentacyclo[10.6.1.0²,¹⁰.0⁴,⁸.0¹⁵,¹⁹]nonadeca-2,4(8),9,14-tetraen-18-yl acetate
C19H21NO6 (359.13688060000004)
(2e)-n-[(2r)-2-hydroxy-2-(4-hydroxy-3-methoxyphenyl)ethyl]-3-(4-hydroxy-3-methoxyphenyl)prop-2-enimidic acid
C19H21NO6 (359.13688060000004)
(1r,9r,10s)-3,6-dihydroxy-4,12-dimethoxy-17-methyl-17-azatetracyclo[7.5.3.0¹,¹⁰.0²,⁷]heptadeca-2,4,6,11-tetraene-8,13-dione
C19H21NO6 (359.13688060000004)
(2r)-3-methyl-1-{4,6,7-trimethoxyfuro[2,3-b]quinolin-5-yl}but-3-ene-2-peroxol
C19H21NO6 (359.13688060000004)
(2e)-n-[(2s)-2-(3,4-dihydroxyphenyl)-2-hydroxyethyl]-3-(3,4-dimethoxyphenyl)prop-2-enimidic acid
C19H21NO6 (359.13688060000004)
(1r,11s,13s,15r,18s)-18-hydroxy-15-methoxy-5,7-dioxa-12-azapentacyclo[10.5.2.0¹,¹³.0²,¹⁰.0⁴,⁸]nonadeca-2,4(8),9,16-tetraen-11-yl acetate
C19H21NO6 (359.13688060000004)
n-[2-(3,4-dihydroxyphenyl)-2-hydroxyethyl]-3-(3,4-dimethoxyphenyl)prop-2-enimidic acid
C19H21NO6 (359.13688060000004)
(9bs,11r,12r)-12-hydroxy-7,8,11-trimethoxy-1h,2h,10h,11h,12h-indolo[7a,1-a]isoquinoline-4,5-dione
C19H21NO6 (359.13688060000004)
17-hydroxy-14-methoxy-5,7-dioxa-12-azapentacyclo[10.6.1.0²,¹⁰.0⁴,⁸.0¹⁵,¹⁹]nonadeca-2,4(8),9,15-tetraen-18-yl acetate
C19H21NO6 (359.13688060000004)
6-[(1e,3e)-4-(3-chloro-1h-pyrrol-2-yl)-3-methylbuta-1,3-dien-1-yl]-2,3,3,7-tetramethyl-2h-furo[3,2-c]pyran-4-one
C20H22ClNO3 (359.1288132000001)
6-[5-(3-chloro-1h-pyrrol-2-yl)penta-2,4-dien-2-yl]-4-methoxy-3-(2-methylbut-3-en-2-yl)pyran-2-one
C20H22ClNO3 (359.1288132000001)
6-[4-(3-chloro-1h-pyrrol-2-yl)-3-methylbuta-1,3-dien-1-yl]-2,3,3,7-tetramethyl-2h-furo[3,2-c]pyran-4-one
C20H22ClNO3 (359.1288132000001)
2-methyl-4-{4,6,7-trimethoxyfuro[2,3-b]quinolin-5-yl}but-3-ene-2-peroxol
C19H21NO6 (359.13688060000004)
methyl 4-[(3s)-3-methoxy-3,7-dimethyl-4,11-dioxo-2-oxa-6-azatricyclo[7.3.1.0⁵,¹³]trideca-1(12),5(13),7,9-tetraen-6-yl]butanoate
C19H21NO6 (359.13688060000004)
12-hydroxy-7,8,11-trimethoxy-1h,2h,10h,11h,12h-indolo[7a,1-a]isoquinoline-4,5-dione
C19H21NO6 (359.13688060000004)
6-[(2e,4e)-5-(3-chloro-1h-pyrrol-2-yl)penta-2,4-dien-2-yl]-4-methoxy-3-(2-methylbut-3-en-2-yl)pyran-2-one
C20H22ClNO3 (359.1288132000001)
(3e)-2-methyl-4-{4,6,7-trimethoxyfuro[2,3-b]quinolin-5-yl}but-3-ene-2-peroxol
C19H21NO6 (359.13688060000004)
(2r)-6-[(1e,3e)-4-(3-chloro-1h-pyrrol-2-yl)-3-methylbuta-1,3-dien-1-yl]-2,3,3,7-tetramethyl-2h-furo[3,2-c]pyran-4-one
C20H22ClNO3 (359.1288132000001)
18-hydroxy-15-methoxy-5,7-dioxa-12-azapentacyclo[10.5.2.0¹,¹³.0²,¹⁰.0⁴,⁸]nonadeca-2,4(8),9,16-tetraen-11-yl acetate
C19H21NO6 (359.13688060000004)